Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹6,658 Cr
Revenue (TTM)
₹1,053 Cr
Net Profit (TTM)
₹294 Cr
ROE
30.9 %
ROCE
41.1 %
P/E Ratio
22.7
P/B Ratio
5.1
Industry P/E
33.39
EV/EBITDA
15.3
Div. Yield
0.3 %
Debt to Equity
0
Book Value
₹74.7
EPS
₹16.9
Face value
2
Shares outstanding
173,465,425
CFO
₹704.27 Cr
EBITDA
₹1,281.36 Cr
Net Profit
₹946.36 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Blue Jet Health
| -27.7 | 5.9 | -27.8 | -56.7 | -- | -- | -- |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
2024
|
|---|---|---|
|
Blue Jet Health
| -8.2 | 53.4 |
|
BSE Small Cap
| -6.6 | 29.0 |
|
BSE Healthcare
| -3.3 | 43.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Blue Jet Health
|
383.3 | 6,657.6 | 1,053.1 | 293.6 | 32.3 | 24.6 | 22.7 | 5.1 |
| 341.2 | 3,112.8 | 2,521.8 | 202.5 | 9.6 | 14.3 | 15.4 | 2.1 | |
| 942.0 | 11,539.7 | 2,512.3 | 543.7 | 28.3 | 19.3 | 21.2 | 3.6 | |
| 1,142.9 | 11,940.9 | 1,158.7 | 309.6 | 31.9 | 17.3 | 38.2 | 6.3 | |
| 1,531.5 | 29,049.9 | 8,850.1 | 894.8 | 15.2 | 19.8 | 33.4 | 5.8 | |
| 12,413.0 | 15,918.8 | 1,575.1 | 179.1 | 14.9 | 11.4 | 88.9 | 9.6 | |
| 1,925.6 | 3,162.1 | 673.7 | 202.6 | 17.6 | 19.4 | 15.6 | 5.5 | |
| 750.0 | 3,444.8 | 588.5 | 102.9 | 22.1 | 12.7 | 33.9 | 4.1 | |
| 622.0 | 7,003.9 | 502.0 | 138.7 | -- | 32.8 | 50.5 | 8.1 | |
| 138.1 | 3,636.7 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 5.5 |
4 min read•By Nipun Arora
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche... pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India. Read more
Incorporated
1968
Chairman
Akshay Bansarilal Arora
Managing Director
Shiven Akshay Arora
Headquarters
Navi Mumbai, Maharashtra
Website
Looking for more details about Blue Jet Healthcare Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of Blue Jet Healthcare Ltd is ₹383.30 (NSE) and ₹383.80 (BSE) as of 18-Mar-2026 IST. Blue Jet Healthcare Ltd has given a return of -56.68% in the last 1 years.
The P/E ratio of Blue Jet Healthcare Ltd is 22.68 times as on 18-Mar-2026, a 32 discount to its peers’ median range of 33.39 times.
The P/B ratio of Blue Jet Healthcare Ltd is 5.14 times as on 18-Mar-2026, a 138 premium to its peers’ median range of 2.16 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
50.06
|
13.48
|
|
2024
|
40.51
|
7.85
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Blue Jet Healthcare Ltd are Rs 1,027.80 and Rs 344.05 as of 19-Mar-2026.
Blue Jet Healthcare Ltd has a market capitalisation of ₹ 6,658 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Blue Jet Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹30.70
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.